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&DIGITAL-MICROFLUIDIC LAB-ON-A-CHIP (LoC) tech-
nology offers a platform for developing diagnostic
applications with the advantages of portability, sample
and reagent volume reduction, faster analysis, increased
automation, low power consumption, compatibility
with mass manufacturing, and high throughput. In
addition to diagnostics, digital microfluidics is finding
use in airborne chemical detection, DNA sequencing by
synthesis, and tissue engineering.
In this article, we review efforts to develop various
LoC applications using electrowetting-based digital
microfluidics. We describe these applications, their
implementation, and associated design issues. The
‘‘Related work’’ sidebar gives a brief overview of
microfluidics technology.
Electrowetting technology
Electrowetting is the phenomenon whereby
an electric field modifies the wetting behavior of
a polarizable or conductive liquid droplet in contact
with a hydrophobic, insulated electrode.1 Figure 1
illustrates this effect. Applying a voltage to a series of
adjacent electrodes that can be turned on or off
creates an interfacial tension gradient
that can manipulate droplets. Droplets
are usually sandwiched between two
parallel plates; the bottom plate is the
chip surface, which houses the address-
able electrode array, and the top is
either a continuous ground plate or
a passive top plate (the chip’s char-
acteristics determine the top plate’s nature).
In coplanar designs, both the buried activation
electrode and the exposed electrodes that ground the
droplet are located on the bottom surface.2,3 As
Figure 2 shows, the top plate is not required for
coplanar devices, but we advise using it to contain the
oil and the droplets. Also, manufacturers or users can
customize the passive top plate with specific chemistry
or structures appropriate for each application. Thus,
the top plate can be a disposable component.
Wehavedemonstrated electrowetting-based systems
for manipulating microliter- and nanoliter-size droplets
in LoC protocols.4–6 Using the electrowetting principle,
we can transport discrete droplets in a highly controlled
way over an array of electrodes. We can reconfigure the
array to transport the droplets or hold the droplets as
virtual reaction chambers where mixing takes place. To
view videos of electrowetting-induced droplet motion,
visit http://www.ee.duke.edu/research/microfluidics
and http://cjmems.seas.ucla.edu/index.html.
The LoC chip surface is coated with an insulating
layer of parylene C (about 800 nm), and both the top
and bottom surfaces are covered with a Teflon-AF thin
Editor’s note:
Digital-microfluidic technology offers a revolutionary platform for many
chemical and biological applications. Learn how to manipulate droplets and
process chemical and biological samples on chip for clinical diagnostics,
gene sequencing, airborne chemical detection, and tissue engineering.
—Krishnendu Chakrabarty, Duke University
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Related work
Much of the reported work on lab-on-a-chip (LoC)
microfluidic devices has focused on miniaturization of
analytical methods and protocols to improve perfor-
mance and throughput. Researchers have demonstrated
the benefits of miniaturization, such as smaller sample
requirements, reduced reagent consumption, de-
creased analysis time, and higher levels of throughput
and automation. Most LoC devices have aimed at
performing chemical or biological protocols on chip,
with pre-prepared samples processed off chip. Thus,
few researchers have reported work on integrating front-
end functions such as sample collection, analyte
extraction, preconcentration, and filtration, with the
required analytical operations then performed on the
chip.1
Currently, almost all microfluidic devices are based
on continuous fluid flow in permanent microchannels in
glass, plastic, or other polymers. De Mello and Beard
present a review of sample pretreatment with continu-
ous-flow microfluidic systems.1 However, continuous-
flow-based microfluidic devices offer very little flexibility
in scalability and reconfigurability, and they are usually
application specific.
An alternative approach to microfluidics is to
manipulate the liquid as unit-sized discrete microdro-
plets. Because of its architectural similarities to digital
microelectronic systems, we often refer to this ap-
proach as ‘‘digital’’ microfluidics. Digital-microfluidic
systems have several advantages over continuous-flow
systems; the most important are reconfigurability and
architecture scalability.2 Electrowetting2 and dielectro-
phoresis3 are the two most commonly used micro-
droplet actuation techniques, although other methods
have been demonstrated, such as thermocapillary
actuation4 and surface acoustic wave actuation.5
Electrowetting is primarily a contact line phenomenon
consisting of electric-field-induced interfacial tension
changes between a liquid and a solid conductor.
The use of electrowetting for dispensing, transport-
ing, splitting, merging, andmixing aqueous droplets has
appeared in the literature previously.2,6–10 Researchers
have addressed the problem of chip surface contami-
nation through biomolecular adsorption by using a sili-
cone oil medium9 or by controlling the application of
actuation voltages.11 Fair et al. demonstrated sample
collection and preconcentration on the same chip.12
Chatterjee et al. demonstrated that a variety of organic
and inorganic substances can be actuated in droplet
form.13 Their results suggest that actuation of non-
conducting liquids might not occur through electrowet-
ting but rather through some other mechanism such as
dielectrophoresis, as others have suggested.14,15
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film (about 50 nm) to ensure a continuous hydropho-
bic platform, which is necessary for smooth droplet
actuation. A spacer separates the top and bottom
plates, resulting in a fixed gap height. The gap is
usually flooded with silicone oil that acts as a filler
fluid, preventing droplet evaporation and reducing
surface contamination.1 Figure 3 shows a typical LoC
platform with multiple electrodes, reservoirs, and
detection sites. The photo is a snapshot of two
pipelined glucose assays in process.5
Unlike a continuous-flow microfluidic platform,
a digital-microfluidic platform operates under soft-
ware-driven electronic control, eliminating the need
for mechanical tubes, pumps, and valves. Digital
platform protocols work similarly to traditional
bench-top methods, except that they use more
automation and significantly smaller sample sizes.
Users can merge, split, transport, mix, and incubate
droplets by programming electrodes to carry out
specific tasks. A digital-microfluidic platform offers
many advantages for real applications. It
& has no moving parts. All operations take place
between the two plates under direct electrical
control without use of pumps or valves.
& requires no channels. The gap is simply filled with
liquid; channels exist only in a virtual sense and
can be instantly reconfigured through software.
& controls many droplets independently because the
electrowetting force is localized at the surface.
& controls or prevents evaporation with the oil
surrounding the droplets.
& uses no ohmic current.Although capacitive currents
exist, the device blocks direct current, minimizing
sample heating and electrochemical reactions.
& works with a wide variety of liquids—that is, most
electrolyte solutions.
& makes close to 100% utilization of
the sample or reagent possible by
wasting no fluid for priming chan-
nels or filling reservoirs.
& is compatible with microscopy.
Glass substrates and transparent
indium-tin-oxide (ITO) electrodes
make the chip compatible with
observation from a microscope.
& is extremely energy efficient—using
nanowatts to microwatts of power
per transfer.
& achieves high droplet speeds—up
to about 25 cm/s.
Figure 1. Electrowetting effect on a digital-microfluidic platform. Because
of the conductive top plate and the individually addressed buried
electrodes in the bottom plate, applying a voltage can actuate the droplet
from one electrode position to the next.
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& uses droplet-based protocols functionally equiva-
lent to bench-scale wet chemistry. Thus, users can
simply scale down, automate, and integrate
established assays and protocols.
& permits maximum operational flexibility. Direct
computer control of each step allows conditional
execution steps.
Applications and design issues
In most diagnostic and chemical detection applica-
tions, a key challenge is the preparation of the analyte
for presentation to the on-chip detection system. In
diagnostics, raw physiological samples must be in-
troduced onto the chip and then further processed by
lysing blood cells and extracting DNA. For massively
parallel DNA sequencing, scientists can prepare
samples off chip, but they must perform synthesis steps
in a sequential on-chip format through automated
control of buffers and nucleotides to extend the read
lengths of DNA fragments. In real-time airborne-
particulate-sampling applications, the process of sam-
ple collection from an air stream must be integrated
into the LoC analytical component. One way to
accomplish this is with a collection droplet that scans
an exposed impacted surface and then is introduced
into a closed analytical section. In tissue-engineering
applications, the challenge is to build high-resolution
(less than 10 microns) 3D tissue constructs with
embedded cells and growth factors by manipulating
and maintaining live cells
on the chip platform.
Here, we highlight these
new applications, includ-
ing detection of airborne
sulfates obtained by air
sampling, DNA pyrose-
quencing, and a biomimet-
ic manufacturing process
for soft-tissue engineering.
On-chip assays
On-chip assays for de-
termining the concentra-
tions of target analytes is
a natural application for
digital microfluidics. Work
in this area has focused on
multiplexed assays, which
measure multiple analytes
in a single sample, as Figure 3 shows. Initially,
scientists must determine the compatibility of each
chemical substance with the electrowetting platform.
Compatibility issues include the following:
& Do the liquid’s viscosity and surface tension
allow droplet dispensing and transport by elec-
trowetting?
Figure 3. Fully automated and integrated operation of a multiplexed assay lab on a chip
(LoC), with two droplets (samples 1 and 2) undergoing pipelined glucose assays.
Figure 2. Coplanar actuation array for droplet scanning: top
view (a) and side view of section A-A (b). Surface electrodes
provide electrical contact to the droplet, making a top contact
plate unnecessary. (This figure is reproduced, with
permission, from R.B. Fair et al., ‘‘Integrated Chemical/
Biochemical Sample Collection, Pre-concentration, and
Analysis on a Digital Microfluidic Lab-on-a-Chip Platform,’’ Lab-
on-a-Chip: Platforms, Devices, and Applications, L.A. Smith
and D. Sobek, eds., Proc. SPIE, vol. 5591, 8 Dec. 2004, pp. 113–
124.)
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& Will the droplet’s contents foul the chip’s
hydrophobic surfaces?
& In systems with a silicone oil medium, will the che-
micals in the droplet cross the droplet-oil interface,
thus reducing the droplet’s content?
Three examples of successful on-chip assay are
glucose, TNT, and sulfate assays. These three exam-
ples use some or all of the following on-chip process
steps:
& Load prediluted sample and reagent into on-chip
reservoirs.
& Dispense droplets of analyte solutions and
reagents.
& Transport droplets.
& Mix analyte solution and reagent droplets.
& Detect reaction products.
Glucose assay
The in vitro measurement of glucose in human
physiological fluids is of great importance in clinical
diagnosis ofmetabolicdisorders. Srinivasan, Pamula, and
Fair have demonstrated an LoC for glucose assay using
a colorimetric enzyme-kineticmethodbasedonTrinder’s
reaction,7 which determines glucose concentration.5
Figure 4 shows a schematic drawing of the assay
detection system.We perform on-chip glucose assay in
three steps: dispensing, mixing, and detection. First,
we pipette droplets of the glucose sample and the
reagent onto the electrowetting chip. The LoC then
merges and physically mixes the sample and the
reagent by shuttling the coalesced droplet across three
electrodes for 15 seconds, at a switching rate of 8 Hz
and an actuation voltage of 50 V. The time for the
mixing protocol is more than is required and can be
reduced to less than five seconds.4 At the end of the
mixing phase, the 545-nm light-emitting-diode (LED)
and photodiode setup measures the absorbance for at
least 30 seconds. Electrowetting forces hold the mixed
droplet stationary during absorbance measurement.
Because absorbance measurement begins 15 seconds
after the droplets merge, the measured reaction rate
might not exactly equal the initial reaction rate.
This device makes detection of glucose concentra-
tions possible in the range of 25 mg/dl to 300 mg/dl,
using dilution factors as low as 2 and 3, in less than 60
seconds. The results compare favorably with conven-
tional measurements on a spectrophotometer, imply-
ing no significant change in enzyme activity under
electrowetting. Reproducibility of the measurement
for the same sample concentration over multiple
measurements on the same chip was less than 2%,
indicating excellent control of droplet volumes and no
cross-contamination.8
Glucose assay design issues
Any efficient or moderate-throughput microfluidic
architecture inevitably requires droplets to share
microfluidic resources on the chip (transport lanes,
mixers, and incubators). Cross-contamination poten-
tially can occur whenever droplets containing differ-
ent samples are manipulated in the same chip area.
Researchers have demonstrated the transport of non-
biological electrolytes using electrowetting both in air9
and in other immiscible media such as silicone oil.5,10
In contrast, the transport of fluids containing proteins,
such as enzyme-laden reagents and human physiolog-
ical fluids, is not as straightforward, because most
proteins adsorb irreversibly to hydrophobic surfaces
and contaminate them. In the electrowetting system,
the liquid droplet is sandwiched between two
hydrophobic (Teflon AF-coated) plates. Any contact
between the liquid droplet and the Teflon AF surface
will therefore contaminate the surface.
In addition to contaminating the surface, protein
adsorption can also render it permanently hydrophil-
ic.11 This effect is detrimental to transport because
electrowetting works on the principle of modifying
a hydrophobic surface’s wettability. Therefore, to
prevent contamination and enable transport, we must
avoid contact between a liquid droplet containing
proteins and the Teflon surface. Thus, air is a less
desirable filler medium for assays involving proteins
because the droplet will always be in contact with the
Teflon surface.9
Researchers have reported exceptions for the use of
air medium systems in applications in which it is
desirable to deposit proteins on surfaces, such as
matrix-assisted laser desorption/ionization mass spec-
trometry (MALDI-MS).12 However, for glucose assays,
silicone oil, with its low surface tension and spreading
property, is an ideal alternative. From visual observa-
tions and electrical capacitance measurements during
the transport of droplets in silicone oil, we have
inferred the presence of a thin film of oil encapsulating
the droplet. This film isolates the droplet from the
Teflon surfaces, minimizing adsorption and facilitating
transport.
Biochips
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Perhaps the most critical step in performing an
assay is dispensing analytes and reagents from the on-
chip reservoirs. The solution content can significantly
affect the process of forming a droplet, particularly if
it’s a protein solution. The problem appears to be
protein absorption in the liquid reservoirs, which have
a far larger surface area than the electrodes.5
Dilution of sample volumes is an important step
in almost all bioanalytical systems. We dilute the
sample primarily for two reasons: to reduce the effect
of interfering substances and to increase the linear
range of device operation. Research has investigated
the problem of obtaining on-chip dilution in a digital-
microfluidic system.13 Dilution requires mixing and
splitting two unit droplets of different concentrations
to produce an intermediate concentration. Unlike
a continuous-flow system, this approach obtains
a range of dilution factors through multiple passes
of the two-droplet mixing and splitting, in various
combinations. The accuracy and repeatability of the
dilution process depends on volume variations in
droplet splitting and concentration variations due to
incomplete mixing. The errors in the dilution factor
are about 15% for dilution factors up to 4, and about
25% for dilution factors between 4 and 8. Droplet
volume variations in dispensing and splitting contrib-
ute to about 80% of this error.
Measurement repeatability is one of the most
important performance metrics of an analytical
method. The two aspects of precision are within-run
precision and day-to-day precision.8 For the electro-
wetting system, within-run precision is mainly affected
by droplet volume errors, cross-contamination be-
tween experiments, and measurement errors. Sriniva-
san performed glucose assays at three different
glucose concentrations.8 He formed sample and
reagent droplets in succession, merged and mixed
them, and then monitored absorbance of the reaction
products for 60 seconds, using the LED-photodiode
setup (Figure 4). Figure 5 shows absorbance as
a function of time for nine assays. The percentage
coefficient of within-run variation for the three
concentrations was within 2%.
TNT assay
An estimated 100 million land mines buried in 65
countries throughout the world pose an enormous
humanitarian problem, killing and mutilating thou-
sands of civilians. The focus of mine detection is to
find and destroy these mines. In addition to land
mine detection, many countries also need chemical
detection of explosives to assess soil and water
contamination. TNT poses a human health risk even
at very low parts-per-billion concentrations in
ground water. Experts suspect it to be a carcinogen
as well as being highly toxic to humans, other
animals, and plants. Thus, the world has a significant
unmet need for rapid, portable, on-site detection of
land mines, unexploded ordnance, and soil con-
taminants.
Researchers obtained preliminary results using an
LoC to detect commercial-grade 2,4,6-trinitrotoluene
(TNT) and pure 2,4-dinitrotoluene (DNT).14 They
performed assays in three steps: dispensing, electro-
wetting-enabled mixing, and colorimetric detection.
They dispensed droplets of TNT and potassium
hydroxide (KOH) by pipette onto the electrowetting
chip. Applying voltages to the appropriate electrodes
merged the two droplets, and transporting the
merged droplet mixed it still further by enhancing
the mixing flow. At the completion of mixing, the LoC
measured absorbance with an LED. All reactions
occurred at room temperature. Figure 6 shows the
measurement results.
Figure 4. Optical absorbance measurement instrumentation
monitors color change due to on-chip colorimetric reactions.
(cSt is centiStokes.)
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The researchers estimated the on-chip method’s
detection limit from the results shown in Figure 6,
assuming that the chip performs the calibration or the
reference reading using only a single concentration.
The lowest detectable concentration corresponds to
about 2.6 mg/ml. If a cubic meter of sampled air
contains 1 mg of TNT (1 femtogram/ml of air), and all
of this particulate is collected on the chip’s sampling
surface and concentrated in a 1-ml droplet, the droplet
will contain a TNT density of 1 mg/ml, or 1,000 mg/ml,
well above the assay’s detection limit. This means that
detection sensitivities in the low attograms (10218 g) of
TNT per ml of air are possible. This level is competitive
with results obtained by Nomadics Inc. with amplify-
ing fluorescent polymers.
Figure 7 shows the absorbance spectra of the color
products resulting from the TNT and DNT assays. The
absorbance peaks of the colored complexes formed
by the reaction of TNT and DNT with KOH are
mutually independent. This means that we can
quantitatively estimate TNT even in the presence of
DNT, which is common when TNT is dissolved in soil.
TNT assay
design issues
Nitroaromatic com-
pounds such as TNT and
DNT react with nucleo-
philes (bases) such as hy-
droxides and alkoxides,
to form colored Jackson-
Meisenheimer complex-
es. Acetone, acetonitrile,
and methanol have been
the most popular solvent
choices for TNT analysis,
even though researchers
have demonstrated this
reaction in various organ-
ic solvents. All three sol-
vents are currently incom-
patible with oil-medium
electrowetting systems be-
cause they are miscible
with silicone oil. Dimethyl
sulfoxide is another versa-
tile solvent that dissolves
most aromatic hydrocar-
bons, including nitroaro-
matics such as TNT, and
yet is immiscible with
silicone oil. Thus, it is
compatible with the electrowetting platform. DMSO is
also completely miscible in all proportions with water
and has a low order of toxicity. For these reasons,
DMSO was the solvent used to develop the TNT
reactions just described. DMSO is also known to
enhance the stability of the Jackson-Meisenheimer
complex.15
Although alkoxides such as sodium methoxide or
potassium methoxide are usually used as the base to
react with nitroaromatics in DMSO, they are not
suitable for a field method because of their high
reactivity with water and their toxicity. That is why the
researchers used KOH as the base in the TNT assay.
Sulfate assay
Another assay developed on a digital-microfluidic
platform is atmospheric sampling of sulfate particles.
Atmospheric particulate matter contributes to adverse
health effects, visibility reduction, and global climate
change, all with significant socioeconomic implica-
tions.16–19 Knowledge of aerosol composition as
Figure 5. Absorbance measured as a function of time for nine serial glucose assays—
three different glucose concentrations (40 mg/dl, 50 mg/dl, and 120 mg/dl) assayed three
times each.8 Here, AU is absorbance units, y is the slope of the linear curve fit, R is
a measure of the deviation of the data from a linear fit, the abscissa x here represents
time, and the equations represent a linear curve fit to the data.
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a function of size is critical to understanding the origin,
properties, and health effects of particulate matter.
Scientists usually measure size-segregated chemical
aerosol composition with cascade impactors. Cascade
impactors collect aerosol on several stages with
progressively smaller cutoff diameters. The aerosol is
impacted on aluminum or Teflon filter substrates,
which are washed in ultrapure water, and the extract is
analyzed. Because the preparation, sampling, and
analysis steps are manual, impactors require consider-
able labor to obtain one sample, making their use
extremely expensive.
Researchers have proposed a scanning droplet
method for automated on-chip measurement of
airborne particulate matter.2,19 The scanning droplet
method is used with a standard cascade impactor.
Technicians perform sample collection by impacting
airborne analyte particles directly on the electrowet-
ting chip’s surface. The surface is then washed with
a microdroplet of solution. The droplet is digitally
directed across the impaction surface, dissolving
sample constituents. Because of the very small droplet
volume used to extract the sample from a wide
collection area, the resulting solution is relatively
concentrated, and thus the analyte can be detected
after a short sampling time (1 minute). After the
washing phase, the droplet is mixed with reagents that
produce colored reaction products. The LoC quanti-
tatively determines the analyte’s concentration by
measuring absorption at target wavelengths using
a simple LED and photodiode setup. Target applica-
tions include quasi-real-time sampling of airborne
contaminants and bioagents, and detection and
quantification of nitroaromatic explosive particles.
Our recent work has aimed at implementing the
methyl thymol blue (MTB) method of sulfate de-
termination.20 Sulfate is the major aerosol component
in the atmosphere, comprising 30% to 80% of fine-
aerosol mass.21 We based the colorimetric detection of
sulfate on Madsen and Murphy’s traditional MTB
method,20 with somemodifications to the reagent com-
position. Ethanol is the traditional reagent solvent, but
it proved incompatible with the digital-microfluidic
platform because of its solubility in silicone oil.22
After testing several alternative solvents, we
obtained the best results with 40% methanol. We
measured absorbance at 608 nm for sulfate de-
tection. The measurements show a linear relation-
ship for sulfate concentration ranging from the
detection limit of 0.5 mg/l to 150 mg/l.
Sulfate assay design issues
For sulfate assay, wemust perform droplet scanning
and sample collection in air without a top plate, so as
not to perturb the impactor air flow. To prevent
evaporation, the scanning droplet can be clad in an oil
encasement that travels through air with the actuated
droplet. We have demonstrated oil cladding by
transporting a droplet through the interface between
the oil medium and the air.2
Figure 8 shows a demonstration of the scanning-
droplet particle collection method.2 We diluted
Figure 6. Calibration curve of absorbance versus TNT
concentration, demonstrating a linear relation on the
electrowetting chip.14
Figure 7. Absorbance spectrum of colored complexes formed
in the reaction of TNT and DNT with KOH, using dimethyl
sulfoxide (DMSO) as the solvent.14
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a solution containing 1-micron-diameter polystyrene
beads and deposited it on the hydrophobic Teflon
surface of an electrowetting chip. After the solvent
dried, a 1-ml water droplet clad with a thin oil film
scanned the bead-coated surface through air. The time
sequence in Figure 8 starts with the upper left frame,
which shows the virgin droplet. The droplet scan
direction in frames 1 through 6 is right to left, and in
the last two frames (7 and 8), the droplet scans left to
right back over the cleaned surface. The droplet picks
up beads efficiently, and does not redeposit them on
the hydrophobic surface after collecting them. When
sample collection is complete, the collection droplet
must move through an air-oil interface into the LoC’s
analytical section. We have not yet demonstrated the
design and reliability of an appropriate on-chip oil-air
interface system.
Integrating optical detectors on a digital-micro-
fluidic platform is relatively easy, especially because
the platform contains plates and see-through,
indium-tin-oxide electrodes. However, optical ab-
sorption detection scales poorly with miniaturization
because Beer’s law incorporates a path length
dependence.23 In the detector shown in Figure 4,
the optical path length is 100 to 300 microns, which is
30 to 100 times smaller than in conventional systems
(10 mm). This small path length poses serious
sensitivity issues.
DNA pyrosequencing
The number of bases in the GenBank genetic
sequence database has increased exponentially, with
a doubling period of approximately 18 months, and
the database currently contains about 3 3 1010 bases,
equivalent to the content of 10 human genomes (a
base is a nucleotide on a DNA strand). In 10 years, the
database will contain the equivalent of approximately
1,000 human genomes, and in 20 years, the equivalent
of 100,000 human genomes. Achieving the productiv-
ity necessary for continued exponential growth of
sequence information will require new, intrinsically
scalable sequencing methods with no inherent
operational limits.
Researchers have proposed using digital-microflui-
dic devices in several competing technologies to
reduce reagent costs, which, along with instrument
cost, are the primary cost of Sanger-based sequencing
(themost common sequencingmethod, developed by
Fred Sanger). These technologies include mass
spectrometry,24 nanopore sequencing,25–27 sequenc-
Figure 8. Scanning-droplet particle collection process. Arrows indicate direction of droplet scan,
and frame numbers show the time sequence. The droplet picks up the deposited 1-micron beads
on the surface, leaving behind a cleaned swath. The droplet does not redeposit beads once it
reverses its scan direction. (This figure is reproduced, with permission, from R.B. Fair et al.,
‘‘Integrated Chemical/Biochemical Sample Collection, Pre-concentration, and Analysis on a Digital
Microfluidic Lab-on-a-Chip Platform,’’ Lab-on-a-Chip: Platforms, Devices, and Applications, L.A. Smith
and D. Sobek, eds., Proc. SPIE, vol. 5591, 8 Dec. 2004, pp. 113–124.)
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ing by hybridization,28–32 sequencing by
synthesis,33 single-molecule sequenc-
ing,34,35 miniaturized electrophoresis,36–38
and miniaturized pyrosequencing (see
http://www.454.com).
On-chip sequencing by synthesis
We are currently evaluating the
digital-microfluidic platform for perform-
ing miniaturized sequencing by synthe-
sis. Sequencing-by-synthesis methods
involve enzymatic extension by poly-
merase through iterative addition of
labeled nucleotides, often in an array
format. The process begins with the
addition of a known nucleotide to the
DNA (or RNA) strand of interest. The
reaction to incorporate a nucleotide is
carried out by DNA polymerase. Upon
nucleotide incorporation, inorganic py-
rophosphate (PPi) is released. The
enzyme ATP sulfurylase converts the
PPi to adenosine triphosphate (ATP),
which then provides energy for the
enzyme lucerifase to oxidize luciferin.
One of the byproducts of this final
oxidation reaction is light generated by
the reaction at approximately 560 nm.
Figure 9 shows this sequence. A photo-
diode, a photomultiplier tube, or a charge-coupled
device (CCD) camera can easily detect the light.39
Because we know the order in which the nucleotide
addition occurs, we can determine the unknown
strand’s sequence by formation of its complementary
strand. The entire pyrosequencing process takes 3 to 4
seconds per nucleotide added.39
Figure 10 shows a preliminary digital-microfluidic
pyrosequencing platform. The chip has reservoirs to
house nucleotides and enzymes. The pyrosequencing
protocol is easy to integrate in such a system. The on-
chip chain of events is as follows:
& The reservoir dispenses a droplet containing
nucleotides of a single type and polymerase, and
the droplet goes to site S, which contains
immobilized single-stranded DNA.
& The droplet incubates, allowing time for poly-
merization.
& The droplet leaves site S and reacts with
luciferase.
& The lucerifase-containing droplet goes to a de-
tector array (not shown in Figure 10).
While the detector array works to detect a light
signal from the droplet, the next nucleotide-containing
droplet enters site S, so that DNA synthesis occurs
simultaneously with detection. This protocol allows
optimized synthesis reactions, and because synthesis
is physically separated from detection, the system has
potentially no inherent limitation on its read length.
Unlike traditional pyrosequencing approaches, this
approach does not limit the system to detecting light
before the next nucleotide is added. The rate-limiting
step in the scheme is the conversion of PPi to ATP-by-
ATP sufurylase. This reaction takes approximately 1.5
seconds, and the incorporation of a base takes less
than 0.5 seconds. The luciferase completes the light
generation in less than 0.2 seconds.39,40 In the existing
solid-phase pyrosequencing protocol, all these reac-
tions must take place before the next nucleotide can
be introduced.
Figure 9. Solid-phase pyrosequencing (sequencing done on a solid platform,
as opposed to a liquid phase). After incorporation of a nucleotide—in this
case, deoxyadenosine triphosphate (dATP)—a washing step removes
excess substrate. For the two strings shown, one is arbitrary DNA, and the
other is complementary to the first string. (ATP is adenosine triphosphate;
PPi is inorganic pyrophosphate.)
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Pyrosequencing design issues
One of the chief design issues for performing
pyrosequencing on an electrowetting chip platform is
DNA immobilization through surface attachment.
Because the platform’s top plate is glass, it opens
new possibilities for surface chemistry and enables
convenient chip reuse. This feature makes attachment
to the top plate appealing and preferable. However,
the top plate must be hydrophobic for droplet
transport, and we have typically used Teflon coatings.
Thus, the challenge is to attach DNA to Teflon.
On-chip DNA immobilization is feasible with gold
particles, although droplet transport over gold particles
dislodges them.41 A better method is to use streptavi-
din, which binds well to aminosilane and glutaralde-
hyde-treated glass top plates. This method requires
patterning the Teflon film to create small access
windows to the treated glass surface. Unlike gold,
which is noncovalent, streptavidin binds covalently to
the Teflon surface, ensuring that the protein remains
attached after droplet transport. Additionally, biotiny-
lated DNA is guaranteed to bind well to streptavidin
because streptavidin has an extremely high affinity for
biotin. Furthermore, commercial pyrosequencing re-
lies on a streptavidin substrate to bind biotinylated
DNA.39 Thus, we can be sure that the reagents used for
pyrosequencing won’t hinder the strep-
tavidin-biotin interaction.
To scale up pyrosequencing so that it
handles multiple DNA fragments in
parallel, we must address basic scientif-
ic and engineering issues involved in
the scaling of an electrowetting-based
microfluidic platform to handle picoliter
droplets. Scaling droplet volumes by
a factor of 1,000 to 1 million from the
current scale translates to linear-dimen-
sion scaling of electrode pitches from
hundreds of microns to 10 microns and
switching times of electrode potentials
from 50 Hz to 10 kHz. Such scaling is
critical to massively parallel on-chip
DNA sequencing at high clock rates.
Thus, sequencing a 1-million-base-pair-
long genome would require 1,000 par-
allel sequencing channels at 1,000 base
pair reads per channel.
On-chip tissue engineering
Tissue engineering (TE) is evolving
as a potential method for the repair and reconstruction
of diseased or damaged tissues.41,42 Doctors have used
TE successfully to replace a blood vessel in pediatric
surgery.43 Nevertheless, the technology faces many
challenges. The primary unmet needs are the follow-
ing:
& manufacturing techniques that can mimic tissue
and extracellular matrix architecture with high
resolution (less than 10 microns) for tissues such
as myocardium (heart muscle), blood vessels,
bone, and nerves;
& digital automation methods for delivery of cells
and growth factors into tissue scaffolds (artificial
structures that support the tissue);44 and
& manufacturing techniques to place vascular
structures in engineered tissue, in which a lack
of nutrient transport currently limits the size and
cellular content of implants.41,42
TE’s major goal is to synthesize or regenerate
functional tissue and organs. Currently, scientists and
doctors attempt to do this by combining cells with an
existing tissue scaffold, culturing them in a controlled
mechanical-biochemical environment, and implanting
them in the body. The scaffold should not only mimic
Figure 10. Advanced Liquid Logic’s prototype pyrosequencing chip, with on-
chip reservoirs for dispensing reagents and nucleotides A, T, C, and G. The
DNA is attached to sample location S.
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the tissue’s biological functions but also provide
mechanical support of the tissue during the recon-
struction process, maintain the tissue’s initially fabri-
cated 3D shape, and protect the tissue from handling
during implantation and in vivo loading. A promising
method of generating a tissue scaffold is electrowetting
printing—embedding cells and growth factors in
hydrogels and printing the hydrogel-containing cells
onto the hydrogel-containing growth factors.45 Work is
underway to develop a new manufacturing system for
3D tissue scaffold and tissue construct fabrication using
biomimetic structure modeling, electrowetting, solid
freeform fabrication, and biomaterials.
A KEY REQUIREMENT FOR fabricating the hydrogel
scaffold is placing thematerials at specific locations on
the chip surface. The hydrogel solution is initially in
solution form, and once it meets a cross-linker
solution, it solidifies. Thus, the hydrogel’s constituents
must be transported or printed on the surface at the
desired location and then reacted. The first experi-
ments performed by us addressed whether a 2%
sodium alginate solution (with a viscosity of 250
centipoise) and a calcium chloride cross-linker
solution could be actuated, dispensed, and reacted
on an electrowetting chip with a silicone oil medium.
On-chip reservoirs dispensed each solution, and the
chip then combined the two droplets by actuating
them into each other. When the droplets moved
together, they rapidly became difficult to actuate,
indicating they had changed to a gel. This is the first
known demonstration of the formation of a solid
phase in an on-chip chemical reaction. At present,
more than 25 groups worldwide are working on
droplet-based electrowetting science and technology,
and the number of papers published each year in this
specialty is growing exponentially. While researchers
are making progress in furthering the understanding of
electrowetting phenomena from a fundamental per-
spective, other efforts are exploring the applications,
novel device structures, and CAD methods possible in
digital microfluidics.46 Efforts in all these areas are
necessary to put the field on a solid footing and to find
the unique niche that the technology can fill.
Investigators have conducted extensive research
on the basic principles and operations underlying the
implementation of electrowetting-based digital-micro-
fluidic systems. The result is a substantial microfluidic
toolkit of automated droplet operations, a sizable
catalog of compatible reagents, and demonstrations of
a few important biological assays. However, a lack of
good on-chip sample preparation methods currently is
the greatest impediment to commercial acceptance of
microfluidic technologies, including digital microflui-
dics. Other issues include system integration and
interfacing to other laboratory formats and devices;
packaging; reagent storage; a way to maintain
temperature control of the LoC during field operation;
and a scalable, compatible detector technology.
Finally, there has been no attempt to implement
molecular separation on a digital-microfluidic platform.
The number and variety of analyses being per-
formed on chip have increased, along with the need to
perform multiple-sample manipulations. It is often desir-
able to isolate components that produce a signal of
interest, so that they can be detected. Currently, mass
separationmethods,suchascapillaryelectrophoresis,are
not part of the digital-microfluidic toolkit, and integration
of separationmethods presents a significant challenge.&
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